Literature DB >> 28622169

Molecular aspects of allergens in atopic dermatitis.

Raffaela Campana1, Sheron Dzoro, Irene Mittermann, Elena Fedenko, Olga Elisyutina, Musa Khaitov, Alexander Karaulov, Rudolf Valenta.   

Abstract

PURPOSE OF REVIEW: Molecular allergology uses pure, mainly recombinant and structurally defined allergen molecules and allergen-derived epitopes to study mechanisms of IgE-associated allergy, to diagnose, and even predict the development of allergic manifestations and to treat and prevent IgE-associated allergies. Atopic dermatitis, a chronic inflammatory skin disease is almost always associated with IgE sensitization to allergens. However, also non-IgE-mediated pathomechanisms seem to be operative in atopic dermatitis and it is often difficult to identify the disease-causing allergens. Here we review recent work showing the usefulness of molecular allergology to study mechanisms of atopic dermatitis, for diagnosis and eventually for treatment and prevention of atopic dermatitis. RECENT
FINDINGS: IgE sensitization to airborne, food-derived, microbial allergens, and autoallergens has been found to be associated with atopic dermatitis. Using defined allergen molecules and non-IgE-reactive allergen derivatives, evidence could be provided for the existence of IgE- and non-IgE-mediated mechanisms of inflammation in atopic dermatitis. Furthermore, effects of epicutaneous allergen administration on systemic allergen-specific immune responses have been studied. Multi-allergen tests containing micro-arrayed allergen molecules have been shown to be useful for the identification of culprit allergens in atopic dermatitis and may improve the management of atopic dermatitis by allergen-specific immunotherapy, allergen avoidance, and IgE-targeting therapies in a personalized medicine approach.
SUMMARY: Molecular allergology allows for dissection of the pathomechanisms of atopic dermatitis, provides new forms of allergy diagnosis for identification of disease-causing allergens, and opens the door to new forms of management by allergen-specific and T cells-targeting or IgE-targeting interventions in a personalized medicine approach.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28622169      PMCID: PMC6392175          DOI: 10.1097/ACI.0000000000000378

Source DB:  PubMed          Journal:  Curr Opin Allergy Clin Immunol        ISSN: 1473-6322


  90 in total

1.  Blocking antibodies induced by specific allergy vaccination prevent the activation of CD4+ T cells by inhibiting serum-IgE-facilitated allergen presentation.

Authors:  R J van Neerven; T Wikborg; G Lund; B Jacobsen; A Brinch-Nielsen; J Arnved; H Ipsen
Journal:  J Immunol       Date:  1999-09-01       Impact factor: 5.422

Review 2.  Revisiting the role of B cells in skin immune surveillance.

Authors:  Isioma U Egbuniwe; Sophia N Karagiannis; Frank O Nestle; Katie E Lacy
Journal:  Trends Immunol       Date:  2015-01-21       Impact factor: 16.687

3.  Role of B cells as antigen-presenting cells in vivo revisited: antigen-specific B cells are essential for T cell expansion in lymph nodes and for systemic T cell responses to low antigen concentrations.

Authors:  A Rivera; C C Chen; N Ron; J P Dougherty; Y Ron
Journal:  Int Immunol       Date:  2001-12       Impact factor: 4.823

4.  α-NAC-Specific Autoreactive CD8+ T Cells in Atopic Dermatitis Are of an Effector Memory Type and Secrete IL-4 and IFN-γ.

Authors:  Lennart M Roesner; Annice Heratizadeh; Susanne Wieschowski; Irene Mittermann; Rudolf Valenta; Britta Eiz-Vesper; Christian Hennig; Gesine Hansen; Christine S Falk; Thomas Werfel
Journal:  J Immunol       Date:  2016-03-09       Impact factor: 5.422

5.  Repetitive immunoadsorption cycles for treatment of severe atopic dermatitis.

Authors:  Georg Daeschlein; Sebastian Scholz; Stine Lutze; Ruediger Eming; Andreas Arnold; Hermann Haase; Michael Hertl; Michael Jünger
Journal:  Ther Apher Dial       Date:  2014-12-16       Impact factor: 1.762

6.  IgE: an immunoglobulin specialized in antigen capture?

Authors:  G C Mudde; T T Hansel; F C von Reijsen; B F Osterhoff; C A Bruijnzeel-Koomen
Journal:  Immunol Today       Date:  1990-12

7.  Early childhood IgE reactivity to pathogenesis-related class 10 proteins predicts allergic rhinitis in adolescence.

Authors:  Marit Westman; Christian Lupinek; Jean Bousquet; Niklas Andersson; Sandra Pahr; Alexandra Baar; Anna Bergström; Mats Holmström; Pär Stjärne; Karin C Lødrup Carlsen; Kaj-Håkon Carlsen; Josep M Antó; Rudolf Valenta; Marianne van Hage; Magnus Wickman
Journal:  J Allergy Clin Immunol       Date:  2014-12-18       Impact factor: 10.793

8.  Molecular, Structural and Immunological Characterization of Der p 18, a Chitinase-Like House Dust Mite Allergen.

Authors:  Yvonne Resch; Katharina Blatt; Ursula Malkus; Christian Fercher; Ines Swoboda; Margit Focke-Tejkl; Kuan-Wei Chen; Susanne Seiberler; Irene Mittermann; Christian Lupinek; Azahara Rodriguez-Dominguez; Petra Zieglmayer; René Zieglmayer; Walter Keller; Vladislav Krzyzanek; Peter Valent; Rudolf Valenta; Susanne Vrtala
Journal:  PLoS One       Date:  2016-08-22       Impact factor: 3.240

9.  Retrospective Analysis on the Effects of House Dust Mite Specific Immunotherapy for More Than 3 Years in Atopic Dermatitis.

Authors:  Jungsoo Lee; Hemin Lee; Seongmin Noh; Byung Gi Bae; Jung U Shin; Chang Ook Park; Kwang Hoon Lee
Journal:  Yonsei Med J       Date:  2016-03       Impact factor: 2.759

10.  Heat-labile Escherichia coli toxin enhances the induction of allergen-specific IgG antibodies in epicutaneous patch vaccination.

Authors:  C R Cabauatan; R Campana; K Niespodziana; C Reinisch; U Lundberg; A Meinke; R Henning; A Neubauer; R Valenta
Journal:  Allergy       Date:  2016-09-30       Impact factor: 13.146

View more
  10 in total

Review 1.  Aeroallergens in Atopic Dermatitis and Chronic Urticaria.

Authors:  Albert C Chong; Won Jong Chwa; Peck Y Ong
Journal:  Curr Allergy Asthma Rep       Date:  2022-04-01       Impact factor: 4.806

Review 2.  Immunological Pathomechanisms of Spongiotic Dermatitis in Skin Lesions of Atopic Dermatitis.

Authors:  Ryoji Tanei; Yasuko Hasegawa
Journal:  Int J Mol Sci       Date:  2022-06-15       Impact factor: 6.208

3.  New and Emerging Therapies for Pediatric Atopic Dermatitis.

Authors:  Henry L Nguyen; Katelyn R Anderson; Megha M Tollefson
Journal:  Paediatr Drugs       Date:  2019-08       Impact factor: 3.930

4.  Paeonol inhibits the development of 1‑chloro‑2,4‑dinitrobenzene‑induced atopic dermatitis via mast and T cells in BALB/c mice.

Authors:  Yujiao Meng; Zhengrong Liu; Chunyan Zhai; Tingting Di; Lu Zhang; Lei Zhang; Xinran Xie; Yan Lin; Ning Wang; Jingxia Zhao; Yan Wang; Ping Li
Journal:  Mol Med Rep       Date:  2019-02-25       Impact factor: 2.952

Review 5.  Autoimmunity (or Not) in Atopic Dermatitis.

Authors:  Lennart M Roesner; Thomas Werfel
Journal:  Front Immunol       Date:  2019-09-10       Impact factor: 7.561

Review 6.  Targeting immunoglobulin E in atopic dermatitis: A review of the existing evidence.

Authors:  Andreas Wollenberg; Simon Francis Thomsen; Jean-Philippe Lacour; Xavier Jaumont; Slawomir Lazarewicz
Journal:  World Allergy Organ J       Date:  2021-03-19       Impact factor: 4.084

7.  Disordered development of gut microbiome interferes with the establishment of the gut ecosystem during early childhood with atopic dermatitis.

Authors:  Min-Jung Lee; Yoon Mee Park; Byunghyun Kim; In Hwan Tae; Nam-Eun Kim; Marina Pranata; Taewon Kim; Sungho Won; Nam Joo Kang; Yun Kyung Lee; Dong-Woo Lee; Myung Hee Nam; Soo-Jong Hong; Bong-Soo Kim
Journal:  Gut Microbes       Date:  2022 Jan-Dec

8.  Ameliorative effects of sea buckthorn oil on DNCB induced atopic dermatitis model mice via regulation the balance of Th1/Th2.

Authors:  Xinxin Wang; Sijia Li; Jiping Liu; Dongning Kong; Xiaowei Han; Ping Lei; Ming Xu; Hongquan Guan; Diandong Hou
Journal:  BMC Complement Med Ther       Date:  2020-08-26

9.  Position Statement on Atopic Dermatitis in Sub-Saharan Africa: current status and roadmap.

Authors:  P Schmid-Grendelmeier; R Takaoka; K C Ahogo; W A Belachew; S J Brown; J C Correia; M Correia; B Degboe; V Dorizy-Vuong; O Faye; L C Fuller; K Grando; C Hsu; K Kayitenkore; N Lunjani; F Ly; G Mahamadou; R C F Manuel; M Kebe Dia; E J Masenga; C Muteba Baseke; A N Ouedraogo; F Rapelanoro Rabenja; J Su; J N Teclessou; G Todd; A Taïeb
Journal:  J Eur Acad Dermatol Venereol       Date:  2019-11       Impact factor: 6.166

10.  [Treatment of atopic dermatitis with dupilumab : A retrospective cohort analysis from dermatological practice].

Authors:  Sigbert Jahn; Julia Föhr; Evangelia Diamanti; Matthias Herbst
Journal:  Hautarzt       Date:  2021-07-30       Impact factor: 0.751

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.